Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
作者: Ryan D. Cassaday , D. Alan Potts , Philip A. Stevenson , Merav Bar , George Georges
DOI: 10.1016/J.BBMT.2014.11.094
关键词: